Title: Future Changes
1Future Changes
Lecture 5
Prof Alan Birchall Internal Dosimetry Course,
SSI, Sweden Nov 16-17 (2006)
2Future Changes
Structure
1. Introduction
2. ICRP Changes
3. IMBA changes
4. Summary
3Future Changes
Structure
1. Introduction
2. ICRP Changes
Dosimetric models Biokinetic models
3. IMBA changes
4. Summary
41. Introduction
Future ICRP changes (2-3 y)
2006 new HAT model
2007 new ICRP recommendations
2007 wound model
2008 new OIR document (part 1)
2008 ICRP guidance document
2009- new OIR document (part 2)
It is highly likely that these will find their
way into EC legislation.
51. Introduction
dosimetry
The essential method of dosimetry will remain the
same
Biokinetic Models will change
Dosimetric Models will change
62. ICRP Changes
dosimetric
New radiation data
72. ICRP Changes
dosimetric
New voxel phantoms
New SAFs
New SEEs
Male and female SEEs
82. ICRP Changes
dosimetric
New wT
92. ICRP Changes
dosimetric
New bone dosimetry
102. ICRP Changes
dosimetric
New bone dosimetry
New microdosimetric structure
Voxel phantoms
Energy dependent SAFs will
112. ICRP Changes
dosimetric
New GI tract dosimetry
Explicitly calculating dose to targets like ICRP
66
Oesophagus basal cells
GI-tract stem cells
122. Current Dosimetry Models
biokinetic
132. ICRP Changes
biokinetic
New HAT model
142. ICRP changes
biokinetic
RT modifications
specific absorption parameters for different
compounds
152. Current Dosimetry Models
Biokinetics
New wound model
Old wound model
solubility
3 types of solid
weak
colloid
moderate
particle
strong
fragment
avid
162. Current Dosimetry Models
Biokinetics (current Pu model)
173. IMBA changes
What needs to be done?
Modify IMBA (and IMBA modules) to deal with the
latest dosimetry and models
- implement recycling directly
- implement new SEEs (label based)
- implement all new systemic models
183. IMBA changes
What needs to be done?
Evolution
- compatible with previous calculations
- extensive quality assurance